Last $4.95 USD
Change Today -0.26 / -4.99%
Volume 12.4K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

biocept inc (BIOC) Snapshot

Open
$5.20
Previous Close
$5.21
Day High
$5.20
Day Low
$4.70
52 Week High
02/5/14 - $10.02
52 Week Low
04/17/14 - $4.70
Market Cap
22.0M
Average Volume 10 Days
15.4K
EPS TTM
--
Shares Outstanding
4.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOCEPT INC (BIOC)

Related News

No related news articles were found.

biocept inc (BIOC) Related Businessweek News

No Related Businessweek News Found

biocept inc (BIOC) Details

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample. The company’s tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. It offers OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company is also developing other OncoCEE CTC tests, including OncoCEE-LU for lung cancer; OncoCEE-GA for gastric cancer; OncoCEE-CR for colorectal cancer; OncoCEE-PR for prostate cancer; and OncoCEE-ME for melanoma. Biocept, Inc. sells its products through its direct sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States, as well as biopharma companies. The company was founded in 1997 and is headquartered in San Diego, California.

27 Employees
Last Reported Date: 03/28/14
Founded in 1997

biocept inc (BIOC) Top Compensated Officers

Executive Chairman
Total Annual Compensation: $342.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $224.9K
Chief Scientific Officer and Senior Vice Pres...
Total Annual Compensation: $216.6K
Vice-President Translational Research and Cli...
Total Annual Compensation: $168.1K
Compensation as of Fiscal Year 2012.

biocept inc (BIOC) Key Developments

Biocept, Inc. Appoints Raaj Trivedi as Vice President, Commercial Operations

Biocept, Inc. announced that it has appointed Raaj Trivedi as Vice President, Commercial Operations. Mr. Trivedi has more than 15 years of leadership experience in biotechnology and diagnostic sales, marketing and business development, primarily focused on targeted therapy solutions in oncology. He joins Biocept from Life Technologies, where he was most recently the Commercial Leader for the Oncomine biomarker discovery platforms. In this role, Mr. Trivedi developed relationships with a large number of biopharmaceutical and academic partners. He was also responsible for integrating the Oncomine solution into Life's next-generation sequencing and companion diagnostic strategies.

Biocept, Inc. Presents at 26th Annual ROTH Conference, Mar-12-2014 10:00 AM

Biocept, Inc. Presents at 26th Annual ROTH Conference, Mar-12-2014 10:00 AM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Michael W. Nall, Chief Executive Officer, President and Director.

Biocept, Inc.(NasdaqCM:BIOC) added to NASDAQ Composite Index

Biocept, Inc. will be added to the NASDAQ Composite Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOC:US $4.95 USD -0.26

BIOC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Atossa Genetics Inc $1.30 USD +0.09
BioMerieux €76.62 EUR -0.54
Fluidigm Corp $37.10 USD +0.75
Illumina Inc $135.45 USD -0.77
Quest Holdings SA €5.40 EUR -0.39
View Industry Companies
 

Industry Analysis

BIOC

Industry Average

Valuation BIOC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 108.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCEPT INC, please visit www.biocept.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.